The p65 subunit of NF-B binds to PGC-1, linking inflammation and metabolic disturbances in cardiac cells

Cardiovascular Research

Volumn 87, Issue 3, 2010, Pages 449-458

  Álvarez Guardia, David ^a   Palomer, Xavier ^a   Coll, Teresa ^a   Davidson, Mercy M ^b   Chan, Tung O ^c   Feldman, Arthur M ^c   Laguna, Juan C ^a   Vázquez Carrera, Manuel ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b Och Spine at New York Presbyterian Hospitals   (United States)

^c THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Inflammation; NF B; PGC 1

Indexed keywords

GENE PRODUCT; GLUCOSE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOGLOBULIN G; PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1; PYRUVATE DEHYDROGENASE KINASE 4; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; AUTACOID; CHUK PROTEIN, MOUSE; HEAT SHOCK PROTEIN; I KAPPA B KINASE; PPARGC1A PROTEIN, HUMAN; PPARGC1A PROTEIN, MOUSE; PROTEIN BINDING; PROTEIN KINASE; RELA PROTEIN, HUMAN; RELA PROTEIN, MOUSE; TRANSACTIVATOR PROTEIN; TRANSCRIPTION FACTOR;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; GENE; GENE OVEREXPRESSION; GENE SILENCING; GLUCOSE METABOLISM; GLUCOSE OXIDATION; HEART FAILURE; HEART MUSCLE CELL; HEART VENTRICLE HYPERTROPHY; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; INFLAMMATION; MALE; METABOLIC DISORDER; MOUSE; NONHUMAN; PDK4 GENE; PGC 1ALPHA GENE; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; ANIMAL; CELL LINE; ENERGY METABOLISM; GENETIC TRANSFECTION; GENETICS; IMMUNOLOGY; METABOLISM; OXIDATION REDUCTION REACTION; PROTEIN ANALYSIS; PROTEIN DOMAIN; RNA INTERFERENCE; TRANSGENIC MOUSE;

ANIMALS; CELL LINE; ENERGY METABOLISM; GLUCOSE; HEAT-SHOCK PROTEINS; HUMANS; I-KAPPA B KINASE; IMMUNOPRECIPITATION; INFLAMMATION; INFLAMMATION MEDIATORS; MALE; MICE; MICE, TRANSGENIC; MYOCYTES, CARDIAC; OXIDATION-REDUCTION; PROTEIN BINDING; PROTEIN INTERACTION DOMAINS AND MOTIFS; PROTEIN INTERACTION MAPPING; PROTEIN KINASES; RNA INTERFERENCE; TRANS-ACTIVATORS; TRANSCRIPTION FACTOR RELA; TRANSCRIPTION FACTORS; TRANSFECTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77954775834     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvq080     Document Type: Article

References (41)

1. Bergman MR, Kao RH, McCune SA, Holycross BJ. Myocardial tumor necrosis factor-alpha secretion in hypertensive and heart failure-prone rats. Am J Physiol 1999;277: H543-H550.
2. Kubota T, McTiernan CF, Frye CS, Slawson SE, Lemster BH, Koretsky AP et al. Dilated cardiomyopathy in transgenic mice with cardiac-specific overexpression of tumor necrosis factor-alpha. Circ Res 1997;81:627-635.
3. Stetson SJ, Perez-Verdia A, Mazur W, Farmer JA, Koerner MM, Weilbaecher DG et al. Cardiac hypertrophy after transplantation is associated with persistent expression of tumor necrosis factor-alpha. Circulation 2001;104:676-681.
4. Gupta S, Young D, Maitra RK, Gupta A, Popovic ZB, Yong SL et al. Prevention of cardiac hypertrophy and heart failure by silencing of NF-kappaB. J Mol Biol 2008; 375:637-649.
5. Finck BN, Kelly DP. Peroxisome proliferator-activated receptor gamma coactivator-1 (PGC-1) regulatory cascade in cardiac physiology and disease. Circulation 2007;115: 2540-2548.
6. Ventura-Clapier R, Garnier A, Veksler V. Transcriptional control of mitochondrial biogenesis: the central role of PGC-1{alpha}. Cardiovasc Res 2008;79:208-217.
7. Palomer X, Alvarez-Guardia D, Rodriguez-Calvo R, Coll T, Laguna JC, Davidson MM et al. TNF-alpha reduces PGC-1alpha expression through NF-kappaB and p38 MAPK leading to increased glucose oxidation in a human cardiac cell model. Cardiovasc Res 2009;81:703-712.
8. Davidson MM, Nesti C, Palenzuela L, Walker WF, Hernandez E, Protas L et al. Novel cell lines derived from adult human ventricular cardiomyocytes. J Mol Cell Cardiol 2005;39:133-147.
9. Ichida M, Nemoto S, Finkel T. Identification of a specific molecular repressor of the peroxisome proliferator-activated receptor gamma coactivator-1 alpha (PGC-1alpha). J Biol Chem 2002;277:50991-50995.
10. Monsalve M, Wu Z, Adelmant G, Puigserver P, Fan M, Spiegelman BM. Direct coupling of transcription and mRNA processing through the thermogenic coactivator PGC-1. Mol Cell 2000;6:307-316.
11. Fan M, Rhee J, St-Pierre J, Handschin C, Puigserver P, Lin J et al. Suppression of mito-chondrial respiration through recruitment of p160 myb binding protein to PGC-1alpha: modulation by p38 MAPK. Genes Dev 2004;18:278-289.
12. Sanjabi S, Williams KJ, Saccani S, Zhou L, Hoffmann A, Ghosh G et al. A c-Rel subdo-main responsible for enhanced DNA-binding affinity and selective gene activation. Genes Dev 2005;19:2138-2151.
13. Nakano H, Shindo M, Sakon S, Nishinaka S, Mihara M, Yagita H et al. Differential regulation of IkappaB kinase alpha and beta by two upstream kinases, NF-kappaB-inducing kinase and mitogen-activated protein kinase/ERK kinase kinase-1. Proc Natl Acad Sci USA 1998;95:3537-3542.
14. Li YY, Chen D, Watkins SC, Feldman AM. Mitochondrial abnormalities in tumor necrosis factor-alpha-induced heart failure are associated with impaired DNA repair activity. Circulation 2001;104:2492-2497.
15. Coll T, Jove M, Rodriguez-Calvo R, Eyre E, Palomer X, Sánchez RM et al. Palmitate-mediated downregulation of peroxisome proliferator receptor g coactivator 1a (PGC-1a) in skeletal muscle cells involves MEK1/2 and NF-kB activation. Diabetes 2006;55:2779-2787.
16. Andrews NC, Faller DV. A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells. Nucleic Acids Res 1991;19: 2499.
17. Caruso M, Miele C, Formisano P, Condorelli G, Bifulco G, Oliva A et al. In skeletal muscle, glucose storage and oxidation are differentially impaired by the IR1152 mutant receptor. J Biol Chem 1997;272:7290-7297.
18. Bentebibel A, Sebastian D, Herrero L, Lopez-Vinas E, Serra D, Asins G et al. Novel effect of C75 on carnitine palmitoyltransferase I activity and palmitate oxidation. Biochemistry 2006;45:4339-4350.
19. Isic A, Scharin TM, Haugen E, Fu M. TNFalpha-antagonist neither improve cardiac remodelling or cardiac function at early stage of heart failure in diabetic rats. Autoim-munity 2008;41:473-477.
20. Duncan JG, Finck BN. The PPARalpha-PGC-1alpha axis controls cardiac energy metabolism in healthy and diseased myocardium. PPAR Res 2008;2008:253817.
21. Shaw J, Yurkova N, Zhang T, Gang H, Aguilar F, Weidman D et al. Antagonism of E2F-1 regulated Bnip3 transcription by NF-kappaB is essential for basal cell survival. Proc Natl Acad Sci USA 2008;105:20734-20739.
22. Jager S, Handschin C, St Pierre J, Spiegelman BM. AMP-activated protein kinase (AMPK) action in skeletal muscle via direct phosphorylation of PGC-1{alpha}. Proc Natl Acad Sci USA 2007;104:12017-12022.
23. Wang LH, Yang XY, Zhang X, Farrar WL. Inhibition of adhesive interaction between multiple myeloma and bone marrow stromal cells by PPARgamma cross talk with NF-kappaB and C/EBP. Blood 2007;110:4373-4384.
24. Sano M, Tokudome S, Shimizu N, Yoshikawa N, Ogawa C, Shirakawa K et al. Intramolecular control of protein stability, subnuclear compartmentalization, and coactivator function of peroxisome proliferator-activated receptor gamma coactivator 1alpha. J Biol Chem 2007;282:25970-25980.
25. Sheppard KA, Rose DW, Haque ZK, Kurokawa R, McInerney E, Westin S et al. Tran-scriptional activation by NF-kappaB requires multiple coactivators. Mol Cell Biol 1999; 19:6367-6378.
26. Knutti D, Kressler D, Kralli A. Regulation of the transcriptional coactivator PGC-1 via MAPK-sensitive interaction with a repressor. Proc Natl Acad Sci USA 2001;98: 9713-9718.
27. Soyal S, Krempler F, Oberkofler H, Patsch W. PGC-1alpha: a potent transcriptional cofactor involved in the pathogenesis of type 2 diabetes. Diabetologia 2006;49: 1477-1488.
28. Meng F, Liu L, Chin PC, D'Mello SR. Akt is a downstream target of NF-kappa B. J Biol Chem 2002;277:29674-29680.
29. Li X, Monks B, Ge Q, Birnbaum MJ. Akt/PKB regulates hepatic metabolism by directly inhibiting PGC-1alpha transcription coactivator. Nature 2007;447:1012-1016.
30. Asada S, Daitoku H, Matsuzaki H, Saito T, Sudo T, Mukai H et al. Mitogen-activated protein kinases, Erk and p38, phosphorylate and regulate Foxo1. Cell Signal 2007; 19:519-527.
31. Daitoku H, Yamagata K, Matsuzaki H, Hatta M, Fukamizu A. Regulation of PGC-1 promoter activity by protein kinase B and the forkhead transcription factor FKHR. Diabetes 2003;52:642-649.
32. Alikhani M, Alikhani Z, Graves DT. FOXO1 functions as a master switch that regulates gene expression necessary for tumor necrosis factor-induced fibroblast apopto-sis. J Biol Chem 2005;280:12096-12102.
33. Olson BL, Hock MB, Ekholm-Reed S, Wohlschlegel JA, Dev KK, Kralli A et al. SCFCdc4 acts antagonistically to the PGC-1{alpha} transcriptional coactivator by targeting it for ubiquitin-mediated proteolysis. Genes Dev 2008;22:252-264.
34. Zhao G, Jeoung NH, Burgess SC, Rosaaen-Stowe KA, Inagaki T, Latif S et al. Overex-pression of pyruvate dehydrogenase kinase 4 in heart perturbs metabolism and exacerbates calcineurin-induced cardiomyopathy. Am J Physiol Heart Circ Physiol 2008;294:H936-H943.
35. Planavila A, Laguna JC, Vázquez-Carrera M. Nuclear factor-kappaB activation leads to down-regulation of fatty acid oxidation during cardiac hypertrophy. J Biol Chem 2005; 280:17464-17471.
36. Miao F, Gonzalo IG, Lanting L, Natarajan R. In vivo chromatin remodeling events leading to inflammatory gene transcription under diabetic conditions. J Biol Chem 2004;279:18091-18097.
37. Zhang P, Liu C, Zhang C, Zhang Y, Shen P, Zhang J et al. Free fatty acids increase PGC-1alpha expression in isolated rat islets. FEBS Lett 2005;579:1446-1452.
38. Lehman JJ, Boudina S, Banke NH, Sambandam N, Han X, Young DM et al. The Tran-scriptional coactivator PGC-1{alpha} is essential for maximal and efficient cardiac mitochondrial fatty acid oxidation and lipid homeostasis. Am J Physiol Heart Circ Physiol 2008;295:H185-H196.
39. Sack MN, Rader TA, Park S, Bastin J, McCune SA, Kelly DP. Fatty acid oxidation enzyme gene expression is downregulated in the failing heart. Circulation 1996;94: 2837-2842.
40. Turner NA, Mughal RS, Warburton P, O'regan DJ, Ball SG, Porter KE. Mechanism of TNFalpha-induced IL-1alpha, IL-1beta and IL-6 expression in human cardiac fibro-blasts: effects of statins and thiazolidinediones. Cardiovasc Res 2007;76:81-90.
41. Ancey C, Menet E, Corbi P, Fredj S, Garcia M, Rucker-Martin C et al. Human cardi-omyocyte hypertrophy induced in vitro by gp130 stimulation. Cardiovasc Res 2003;59: 78-85.